RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$68.94
Tradestie Score
49
Market Cap
$6.00B
Revenue Growth
0.3%
Analyst Upside
+37.3%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRL
Charles River Laboratories International, Inc.
|
$295.01
|
$8.39B | - | 42 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$178.36
|
$7.81B | - | 46 | Compare |
|
BLLN
BLLN
|
$106.44
|
$5.58B | 164.1 | 39 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.49
|
$4.60B | 32.6 | 61 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$99.53
|
$3.51B | 23.9 | 44 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$72.30
|
$3.26B | - | 55 | Compare |
|
VCYT
Veracyte, Inc.
|
$46.04
|
$2.85B | 32.9 | 37 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$13.87
|
$2.72B | - | 49 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$140.12
|
$2.24B | - | 38 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$28.90
|
$2.22B | - | 38 | Compare |
More RDNT Analysis
Data updated: Sep 30, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry